PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.
Amyotrophic lateral sclerosis (ALS) is a devastating, rapidly progressive disease leading to paralysis and death. Recently, intermediate length polyglutamine (polyQ) repeats of 27-33 in ATAXIN-2 (ATXN2), encoding the ATXN2 protein, were found to increase risk for ALS. In ATXN2, polyQ expansions of ≥...
Main Authors: | Zhenming Yu, Yongqing Zhu, Alice S Chen-Plotkin, Dana Clay-Falcone, Leo McCluskey, Lauren Elman, Robert G Kalb, John Q Trojanowski, Virginia M-Y Lee, Vivianna M Van Deerlin, Aaron D Gitler, Nancy M Bonini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-03-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3066214?pdf=render |
Similar Items
-
PolyQ Tract Toxicity in SCA1 is Length Dependent in the Absence of CAG Repeat Interruption
by: Suran Nethisinghe, et al.
Published: (2018-07-01) -
In Vitro Expansion of CAG, CAA, and Mixed CAG/CAA Repeats
by: Grzegorz Figura, et al.
Published: (2015-08-01) -
Repeats expansions in ATXN2, NOP56, NIPA1 and ATXN1 are not associated with ALS in Africans
by: Melissa Nel, et al.
Published: (2021-06-01) -
Co‐occurrence of ATXN3 and ATXN2 repeat expansions in Chinese ataxia patients with slow saccades
by: Chao Wu, et al.
Published: (2019-06-01) -
Repeat Associated Non-AUG Translation (RAN Translation) Dependent on Sequence Downstream of the ATXN2 CAG Repeat.
by: Daniel R Scoles, et al.
Published: (2015-01-01)